Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.45 |
| ▸ | PTGDR2 | Q9Y5Y4 | 2/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 4/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | CASP1 | P29466 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | NAAA | Q02083 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | HTR1A | P08908 | 1/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | DRD1 | P21728 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25188997 | 0.99 | SLC6A2 (0.43) | TSHRPTGDR2L3MBTL1SLC6A2SLC6A3 | |
| SCHEMBL11467456 | 0.86 | PTGDR2 (0.43) | TSHRPTGDR2SLC6A2SLC6A3SLC6A4 | |
| SCHEMBL2062805 | 0.84 | PTGDR2 (0.41) | TSHRPTGDR2SLC6A2SLC6A3SLC6A4 | |
| SCHEMBL1222346 | 0.84 | PTGDR2 (0.41) | TSHRPTGDR2SLC6A2SLC6A3SLC6A4 | |
| SCHEMBL2062415 | 0.84 | PTGDR2 (0.41) | TSHRPTGDR2SLC6A2SLC6A3SLC6A4 | |
| SCHEMBL7914136 | 0.83 | PTGDR2 (0.40) | TSHRPTGDR2SLC6A2SLC6A3SLC6A4 | |
| SCHEMBL7905925 | 0.82 | PTGDR2 (0.40) | TSHRPTGDR2SLC6A2SLC6A3SLC6A4 | |
| SCHEMBL3364418 | 0.82 | PTGDR2 (0.38) | TSHRPTGDR2SLC6A2SLC6A3SLC6A4 | |
| Bromide SCHEMBL17076630 | 0.82 | SLC6A2 (0.34) | TSHRPTGDR2L3MBTL1SLC6A2SLC6A3 | |
| Bromide SCHEMBL17076633 | 0.82 | SLC6A2 (0.34) | TSHRPTGDR2L3MBTL1SLC6A2SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10449173-B2 | Method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions | ALLERGAN SALES, LLC (US) | 2019-10-22 | — | — | US | disclosed |
| EP-3287122-B1 | DEVICE FOR STORAGE AND ADMINISTRATION OF TOPICAL OXYBUTYNIN COMPOSITIONS FOR TREATING OVERACTIVE BLADDERS. | ALLERGAN SALES LLC (US) | 2019-04-17 | — | — | EP | disclosed |
| EP-3287122-A1 | A METHOD FOR TREATING OVERACTIVE BLADDERS AND A DEVICE FOR STORAGE AND ADMINISTRATION OF TOPICAL OXYBUTYNIN COMPOSITIONS | Allergan Sales, LLC (US) | 2018-02-28 | — | — | EP | disclosed |
| EP-2427172-B1 | A METHOD FOR TREATING OVERACTIVE BLADDERS AND A DEVICE FOR STORAGE AND ADMINISTRATION OF TOPICAL OXYBUTYNIN COMPOSITIONS | ALLERGAN SALES LLC (US) | 2017-11-01 | — | — | EP | disclosed |
| US-20160128963-A1 | METHOD FOR TREATING OVERACTIVE BLADDERS AND A DEVICE FOR STORAGE AND ADMINISTRATION OF TOPICAL OXYBUTYNIN COMPOSITIONS | WATSON LABORATORIES, INC. | 2016-05-12 | — | — | US | disclosed |
| US-9259388-B2 | Method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions | WATSON PHARMACEUTICALS, INC. (US) | 2016-02-16 | — | — | US | disclosed |
| US-8920392-B2 | Method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions | WATSON LABORATORIES, INC. (US) | 2014-12-30 | — | — | US | disclosed |
| US-20140046275-A1 | Method for Treating Overactive Bladders and a Device for Storage and Administration of Topical Oxybutynin Compositions | WATSON LABORATORIES, INC. (US) | 2014-02-13 | — | — | US | disclosed |
| EP-2427172-A2 | A METHOD FOR TREATING OVERACTIVE BLADDERS AND A DEVICE FOR STORAGE AND ADMINISTRATION OF TOPICAL OXYBUTYNIN COMPOSITIONS | Watson Laboratories, Inc. (US) | 2012-03-14 | — | — | EP | disclosed |
| WO-2010129498-A2 | A METHOD FOR TREATING OVERACTIVE BLADDERS AND A DEVICE FOR STORAGE AND ADMINISTRATION OF TOPICAL OXYBUTYNIN COMPOSITIONS | WATSON LABORATORIES, INC. (US) | 2010-11-11 | — | — | WO | disclosed |
| US-20100286630-A1 | Method For Treating Overactive Bladders And A Device For Storage And Administration Of Topical Oxybutynin Compositions | WATSON LABORATORIES, INC. (US) | 2010-11-11 | — | — | US | disclosed |